CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1988; 38:362-367
doi: 10.3322/canjclin.38.6.362
© 1988 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahour, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahour, G. H.

CA: A Cancer Journal for Clinicians, Vol 38, 362-367, Copyright © 1988 by American Cancer Society


Sacrococcygeal Teratomas

G. Hossein Mahour MD1

1 Head of the Division of Pediatric Surgery of Childrens Hospital of Los Angeles, and Professor of Surgery at the University of Southern California School of Medicine, in Los Angeles, California.

In conclusion, treatment of malignant sacrococcygeal teratoma remains a problem, and the prognosis for patients with this disease is poor. Recurrence after excision of an overtly malignant tumor is common and carries a high risk of mortality. Long-term survival of patients with recurrent malignant sacrococcygeal teratoma is rare regardless of the therapy used. Aggressive surgical therapy is recommended. Adjuvant chemotherapy and radiotherapy should be used, although the ideal combination of agents remains to be determined. Postoperative therapy is best formulated in a tumor-board setting with appropriate input by knowledgeable surgeons, radiotherapists, and oncologists. Through cooperative tive efforts and careful follow-up, the best methods of therapy can be formulated to help increase the survival of patients with malignant sacrococcygeal teratomas.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
M Monteiro, T M Cunha, A Catarino, and V Tome
Sacrococcygeal teratoma with malignant transformation in an adult female: CT and MRI findings
Br. J. Radiol., July 1, 2002; 75(895): 620 - 623.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by American Cancer Society.